Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Rheumatic Diseases Clinics of North America|November 10, 2012
Malignancy risks with biologic therapiesJohn J Cush, Kathryn H Dao
Rheumatic Diseases Clinics of North America|November 10, 2012
Nonserious infections: should there be cause for serious concerns?Kathryn H Dao, Morley Herbert, Nadia Habal, et al.
The Journal of Rheumatology|December 17, 2009
Can tumor necrosis factor inhibitors be safely used in pregnancy?Yaser M Ali, Bindee Kuriya, Catalina Orozco, et al.
The Journal of Rheumatology|April 3, 2019
Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network RegistryBrooke S Mills, Kathryn H Dao, Kristen M Tecson, et al.
The Journal of Rheumatology|November 3, 2015
Pregnancy Outcomes in Subjects Exposed to Certolizumab PegolMegan E B Clowse, Douglas C Wolf, Frauke Förger, et al.
Seminars in Arthritis and Rheumatism|May 24, 2012
Proceedings of the 2012 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, George Martin, John J Cush, et al.
The Journal of Rheumatology. Supplement|February 6, 2009
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidenceStanley B Cohen, Marc D Cohen, John J Cush, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2018
Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety DatabaseMegan E B Clowse, Angela E Scheuerle, Christina Chambers, et al.
Pageof 3